You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis

Citation Tools

Article menu
Clinical/translational cancer immunotherapy
Original research
Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ma Y, Liu N, Wang Y, et al
Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis
Journal for ImmunoTherapy of Cancer 2021;9:e003712. doi: 10.1136/jitc-2021-003712